Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) | MicrobiomeTrials

← Back to trials

NCT05925803

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2023-11-08Est. Completion: 2027-01-06

Enrollment target: 314 participants

Locations

Research Site, Scottsdale, Arizona, United States
Research Site, Chula Vista, California, United States
Research Site, Los Angeles, California, United States
Research Site, Orange, California, United States
Research Site, Aurora, Colorado, United States
Research Site, New Haven, Connecticut, United States
Research Site, Washington D.C., District of Columbia, United States
Research Site, Boca Raton, Florida, United States
Research Site, Fort Lauderdale, Florida, United States
Research Site, Gainesville, Florida, United States
Research Site, Jacksonville, Florida, United States
Research Site, Margate, Florida, United States
Research Site, South Miami, Florida, United States
Research Site, Tamarac, Florida, United States
Research Site, Chicago, Illinois, United States
Research Site, Kansas City, Kansas, United States
Research Site, New Orleans, Louisiana, United States
Research Site, Baltimore, Maryland, United States

Other microbiome trials you might be interested in

Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1Completed

SclerodermaSystemic Sclerosis

Sharing research results with patients is required by ethical regulations. Yet, most researchers do not share results fr…

Montreal, CanadaCompleted Dec 19, 2025

Study of Families With Twins or Siblings Discordant for Rheumatic DisordersCompleted

Rheumatoid ArthritisSystemic Lupus ErythematosusIdiopathic Inflammatory Myopathies

This study will examine families in which one sibling of a sibling pair, or twin pair, has developed a systemic rheumati…

Bethesda, United States

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.